This compound is a customized synthesis product. We have a strong synthesis team with excellent synthesis technology and capabilities. However, due to various objective factors, there is a low probability that the synthesis will not be successful. If you need to learn more, please feel free to consult us, we will serve you wholeheartedly.
This compound is a customized synthesis product. We have a strong synthesis team with excellent synthesis technology and capabilities. However, due to various objective factors, there is a low probability that the synthesis will not be successful. If you need to learn more, please feel free to consult us, we will serve you wholeheartedly.
BMS-986143
Catalog No. T39129 CAS
1643372-95-5
BMS-986143, an orally active, reversible BTK inhibitor with an IC50 value of 0.26 nM, is designed for autoimmune disease research. Additionally, it targets TEC, BLK, BMX, TXK, FGR, YES1, and ITK, exhibiting IC50s of 3 nM, 5 nM, 7 nM, 10 nM, 15 nM, 19 nM, and 21 nM, respectively [1].
All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
This compound is a customized synthesis product. We have a strong synthesis team with excellent synthesis technology and capabilities. However, due to various objective factors, there is a low probability that the synthesis will not be successful. If you need to learn more, please feel free to consult us, we will serve you wholeheartedly.
Contact us for more batch information
Biological Description
Chemical Properties
Storage
& Solubility Information
Description
BMS-986143, an orally active, reversible BTK inhibitor with an IC50 value of 0.26 nM, is designed for autoimmune disease research. Additionally, it targets TEC, BLK, BMX, TXK, FGR, YES1, and ITK, exhibiting IC50s of 3 nM, 5 nM, 7 nM, 10 nM, 15 nM, 19 nM, and 21 nM, respectively [1].
In vitro
BMS-986143 effectively inhibits Bruton's tyrosine kinase (BTK) activity, demonstrating potent inhibitory effects across a variety of assays. Notably, it shows IC50 values of 6.9±3.4 nM in Ramos cellular assays and 25±19 nM in human whole blood assays. Further, it significantly inhibits signaling related to IgG-containing immune complex activation via low-affinity Fcγ receptors in peripheral blood mononuclear cells (PBMC) with an IC50 of 2 nM. Additionally, BMS-986143 suppresses CD63 expression on basophils in response to FcεRI signaling in human whole blood (IC50=54 nM) and inhibits calcium flux, proliferation of human peripheral B Cells, CD86 surface expression in peripheral B Cells, and TNFα production in human PBMC Cells with IC50 values of 7±3, 1±0.4, 1±0.5, and 2 nM, respectively.
In vivo
BMS-986143 demonstrates effective treatment in mouse models of both collagen-induced arthritis (CIA) and anticollagen antibody-induced arthritis (CAIA), showcasing high oral bioavailability in mice (100%) and dogs (82%), and moderate peak plasma concentrations (Cmax) of 4.3 μM in mice and 1.2 μM in dogs when administered orally at doses of 6 mg/kg for mice and 2 mg/kg for dogs. It also has prolonged elimination half-lives of 3.6 hours in mice and 7.9 hours in dogs, attributable to its moderate plasma clearance rates (8.6 mL/min/kg for mice and 4.4 mL/min/kg for dogs) and low distribution volumes (1.8 L/kg for mice and 2.6 L/kg for dogs), after intravenous doses of 3.0 mg/kg for mice and 1.0 mg/kg for dogs. In trials with DBA/1 male mice aged 8-10 weeks exhibiting CIA, oral administration of BMS-986143 at 15 and 45 mg/kg twice daily resulted in dose-dependent reduction of clinical disease progression (63% and 80% inhibition, respectively), corresponding to 17 and 19 hours of effective coverage based on the mouse whole blood IC50 of 130 nM.
Molecular Weight
587.45
Formula
C31H24Cl2N4O4
CAS No.
1643372-95-5
Storage
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Method for preparing DMSO master liquid: mg
drug pre-dissolved in μL DMSO (Master liquid concentration
mg/mL),
Method for preparing in vivo formulation:Take μL
DMSO master liquid, next add μL PEG300, mix and clarify, next add μL
Tween 80,mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation:Take μL
DMSO master liquid, next add μL Corn oil,mix and clarify.
Note:
Be sure to add the solvent(s) in order. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
Calculator
Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
bottom
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.